Australian-New Zealand Clinical Trial: A rapid assessment and treatment pathway using targeted therapy and immunotherapy for people with anaplastic thyroid cancer

Australia, Nov. 4 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘A rapid assessment and treatment pathway using targeted therapy and immunotherapy for people with anaplastic thyroid cancer’. The following are the other relevant details related to the trial:

Trial ID: 392697

Submit Date: 9/18/26 15:37

Study Type: Interventional

Intervention: Drug treatments are not supplied, funded or allocated by this trial. No trial funding is available for study drugs. All agents named below are TGA-registered but not all are PBS-subsidised for anaplastic thyroid cancer. Where a participant and their treating team elect to pursue one of these treatments, access is sought for that indiv...